title: Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain.
abstract: Acinetobacter baumannii has been identified by the Infectious Diseases Society of America as one of the six pathogens that cause majority of hospital infections. Increased resistance of A.baumannii even to the latest generation of β-lactams like carbapenem is an immediate threat to mankind. As inner-membrane fraction plays a significant role in survival of A.baumannii, we investigated the inner-membrane fraction proteome of carbapenem-resistant strain of A.baumannii using Differential In-Gel Electrophoresis (DIGE) followed by DeCyder, Progenesis and LC-MS/MS analysis. We identified 19 over-expressed and 4 down-regulated proteins (fold change>2, p<0.05) in resistant strain as compared to reference strain. Some of the upregulated proteins in resistant strain and their association with carbapenem resistance in A.baumannii are: i) β-lactamases, AmpC and OXA-51: cleave and inactivate carbapenem ii) metabolic enzymes, ATP synthase, malate dehydrogenase and 2-oxoglutarate dehydrogenase: help in increased energy production for the survival and iii) elongation factor Tu and ribosomal proteins: help in the overall protein production. Further, entry of carbapenem perhaps is limited by controlled production of OmpW and low levels of surface antigen help to evade host defence mechanism in developing resistance in A.baumannii. Present results support a model for the importance of proteins of inner-membrane fraction and their synergistic effect in the mediation of resistance of A.baumannii to carbapenem.
authors: Department of Biochemistry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
authors: Vishvanath
authors: V
authors: Tiwari
authors: Jitendraa
authors: J
authors: Vashistt
authors: Arti
authors: A
authors: Kapil
authors: Rajeswari R
authors: RR
authors: Moganty
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D040981:Acinetobacter baumannii / Q000235:genetics / Q000378:metabolism*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D015780:Carbapenems / Q000627:therapeutic use*; D015536:Down-Regulation; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D040901:Proteomics; D053719:Tandem Mass Spectrometry; D015854:Up-Regulation
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems